MoneyWorks4Me

Eiko Lifesciences informs about disclosure

17 May 2022 Evaluate

Eiko Lifesciences has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra (HUF).

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Godrej Industries 1021.20
SRF 2490.00
BASF India 3411.40
Pidilite Inds. 1470.00
Tata Chemicals 607.90
View more..